Biomx INC Schedule 13G passive stakes

An amendment to a Schedule 13G filing reveals that a group including Rodney Hodges, Geneva Holding Company, and Telmina Limited has reduced its beneficial ownership of BiomX Inc. common stock to 0.7%.

A group of investment entities led by Rodney Hodges has disclosed a 5.2% beneficial ownership stake in BiomX Inc.

Nantahala Capital Management, LLC and its managing members reported a 9.99% beneficial ownership stake in BiomX Inc. as of December 31, 2025.

AIGH Capital Management LLC and Orin Hirschman have filed an amended Schedule 13G, reporting a 0.1% beneficial ownership stake in BioMX Inc. as of December 31, 2025.

Morgan Stanley and its subsidiary have reported ceasing beneficial ownership of more than five percent of BiomX Inc.'s common stock.

Morgan Stanley and its subsidiary have reported a 7.1% beneficial ownership stake in BiomX Inc.'s common stock, held in the ordinary course of business.

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, has reported a beneficial ownership of 9.99% in BiomX Inc.'s common stock as of March 31, 2025.

Alyeska Investment Group, L.P., along with its affiliates, has reported a significant passive ownership stake of 9.27% in BiomX Inc., totaling 2,316,076 shares.

A group of entities and an individual, led by Rodney Hodges, have disclosed a passive beneficial ownership stake of up to 7.6% in BiomX Inc., including warrants, as detailed in a recent Schedule 13G filing.

Investment entities AIGH Capital Management LLC and Orin Hirschman have jointly reported a passive 6.3% beneficial ownership stake in BioMX Inc., totaling 1,566,944 common shares.

The Cystic Fibrosis Foundation has filed an amendment to its Schedule 13G, disclosing a 9.99% beneficial ownership stake in BiomX Inc. as of February 27, 2025.

The Cystic Fibrosis Foundation has filed an amended Schedule 13G, reaffirming its beneficial ownership of 19.99% of BiomX Inc.'s common stock as of September 30, 2024.